HomeCYCC • NASDAQ
add
Cyclacel Pharmaceuticals Inc
Previous close
$0.42
Day range
$0.39 - $0.42
Year range
$0.31 - $4.00
Market cap
2.48M USD
Avg Volume
4.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.00K | -37.50% |
Operating expense | 2.19M | -68.12% |
Net income | -1.96M | 67.56% |
Net profit margin | -19.57K | 48.09% |
Earnings per share | -0.18 | 97.55% |
EBITDA | -2.18M | 68.18% |
Effective tax rate | 9.69% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.98M | -49.83% |
Total assets | 5.38M | -56.94% |
Total liabilities | 6.35M | -22.55% |
Total equity | -970.00K | — |
Shares outstanding | 6.29M | — |
Price to book | -0.93 | — |
Return on assets | -80.21% | — |
Return on capital | -32,014.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.96M | 67.56% |
Cash from operations | -3.07M | 24.01% |
Cash from investing | — | — |
Cash from financing | -1.00K | 98.00% |
Net change in cash | -3.02M | 28.48% |
Free cash flow | -2.31M | 8.20% |
About
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Founded
Aug 13, 1996
Headquarters
Website
Employees
12
